Spark Plus

975 posts

Spark Plus banner
Spark Plus

Spark Plus

@Spark_Plus

Spark Plus is a Corporate Finance Advisor (Exempt Status by MAS) for small/mid-cap listed-companies that may not have the best coverage in APAC.

Singapore, Japan, Australia انضم Ağustos 2017
280 يتبع343 المتابعون
Spark Plus أُعيد تغريده
CommSec
CommSec@CommSec·
[REPORT] Week Ahead: Aussie jobs and Chinese economic growth data in focus as the European Central Bank (ECB) meets commsec.com.au/content/dam/EN… #ausecon
CommSec tweet media
English
0
5
10
3.5K
Spark Plus أُعيد تغريده
Power Minerals Limited (ASX:PNN)
$PNN team onsite as it plans to adopt its successful exploration strategy from the Nióbio Project, which has returned high-grade niobium, tantalum and REE results, to advance the Tântalo Project. The Tântalo Project consists of 12 granted permits covering 5,780.54 hectares (57.80km2). The permits include a number of Garimpo Licence titles, which provide a potentially easier and shorter approval pathway to allow the commencement of on-ground fieldwork, which includes drilling.
Power Minerals Limited (ASX:PNN) tweet media
English
0
9
29
733
Spark Plus أُعيد تغريده
Lel Smits
Lel Smits@LelSmits·
Supporting @Spark_Plus Australian Equities Day in #Singapore highlighted why investors like to meet management in person with investors telling me on the panel, "Management is everything"... @TheStockNet CEO interviews ⚡️ youtube.com/watch?v=t7z7g9… Featuring 👇 @WeAreArovella $ALA @ActivePortGroup $ATV @FBR $FBR @ltd_gti $GTR @bcal_dx $BDX @Airtasker $ATR @PharmAust $PAA @AltechBatteries $ATC @LithiumUniverse $LU7 @EZZLifeScience $EZZ @blink_lab $BB1
YouTube video
YouTube
English
0
2
10
441
Spark Plus أُعيد تغريده
Syntara Limited
Syntara Limited@SyntaraTx·
Syntara was delighted to take part in the @Spark_Plus Australian Equities Day at Marina Bay Sands, Singapore. With over 150 attendees, the event offered an excellent platform to present our progress in developing innovative treatments for #myelofibrosis, a serious blood cancer. We also shared updates on our clinical trials, particularly highlighting our lead candidate, SNT-5505. $SNT #SparkPlus #ASX
Syntara Limited tweet mediaSyntara Limited tweet mediaSyntara Limited tweet media
English
0
1
6
184